Terms: = Lymphoma AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
1035 results:
1. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract] [Full Text] [Related]
2. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
3. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions.
Deng H; Han Y; Liu L; Zhang H; Liu D; Wen J; Huang M; Zhao L
J Med Chem; 2024 Apr; 67(8):5963-5998. PubMed ID: 38597264
[TBL] [Abstract] [Full Text] [Related]
4. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
5. [Studies on clinicopathological features of duodenal-type follicular lymphoma of 18 patients].
Du YR; Li J; Li SX; Guan CY; Li HL; Gao ZF; Li X; Dong GH
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):94-97. PubMed ID: 38527846
[TBL] [Abstract] [Full Text] [Related]
6. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract] [Full Text] [Related]
7. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell lymphoma and Clinical Significance].
Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
[TBL] [Abstract] [Full Text] [Related]
8. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
9. Pretargeted radiotherapy and synergistic treatment of metastatic, castration-resistant prostate cancer using cross-linked, PSMA-targeted lipoic acid nanoparticles.
Dai L; Zhang X; Zhou S; Li J; Pan L; Liao C; Wang Z; Chen Y; Shen G; Li L; Tian R; Sun H; Liu Z; Zhang S; Wu H
J Mater Chem B; 2024 Feb; 12(9):2324-2333. PubMed ID: 38324337
[TBL] [Abstract] [Full Text] [Related]
10. CEBPA facilitates LOXL2 and LOXL3 transcription to promote bcl-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract] [Full Text] [Related]
11. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
Wang WT; Xing TY; Du KX; Hua W; Guo JR; Duan ZW; Wu YF; Wu JZ; Li Y; Yin H; Shen HR; Wang L; Li JY; Liang JH; Xu W
Cancer Lett; 2024 Feb; 583():216616. PubMed ID: 38211650
[TBL] [Abstract] [Full Text] [Related]
12. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
[TBL] [Abstract] [Full Text] [Related]
13. Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas.
Watanabe T
World J Gastroenterol; 2023 Dec; 29(48):6179-6197. PubMed ID: 38186866
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
[No Abstract] [Full Text] [Related]
15. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
[TBL] [Abstract] [Full Text] [Related]
16. Vitamin K: New insights related to senescence and cancer metastasis.
Chen A; Li J; Shen N; Huang H; Hang Q
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189057. PubMed ID: 38158025
[TBL] [Abstract] [Full Text] [Related]
17. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
18. PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not otherwise specified: A case report and review of literature.
Han X; Liu X; Zhang C; Wen Q; Zhang X
J Cancer Res Ther; 2023 Dec; 19(6):1680-1684. PubMed ID: 38156938
[TBL] [Abstract] [Full Text] [Related]
19. [miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9].
Li B; Tao Q; Hu X; Li T; Bao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1074-1082. PubMed ID: 38140866
[TBL] [Abstract] [Full Text] [Related]
20. m6A-related lncRNAs as potential biomarkers and the lncRNA ELFN1-AS1/miR-182-5p/bcl-2 regulatory axis in diffuse large B-cell lymphoma.
Yang Q; Lu Y; Du A
J Cell Mol Med; 2024 Jan; 28(2):e18046. PubMed ID: 38037859
[TBL] [Abstract] [Full Text] [Related]
[Next]
